Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis.
A peptide nucleic acid (PNA)-mediated polymerase chain reaction clamping allows the selective inhibition of the ERVWE1 gene amplification.
Hsp70 regulates immune response in experimental autoimmune encephalomyelitis.
Pivotal role of choline metabolites in remyelination.
Focal transient CNS vessel leak provides a tissue niche for sequential immune cell accumulation during the asymptomatic phase of EAE induction.
A specific vaccine to protect patients with multiple sclerosis from herpes zoster.
Benign Multiple Sclerosis is Associated with Reduced Thinning of the Retinal Nerve Fiber and Ganglion Cell Layers in Non-Optic-Neuritis Eyes.
Extensive vascular remodeling in the spinal cord of pre-symptomatic experimental autoimmune encephalomyelitis mice; increased vessel expression of fibronectin and the α5β1 integrin.
Clinical and demographic factors affecting disease severity in patients with multiple sclerosis.
Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis.
Guideline for the diagnosis and management of multiple sclerosis: A Southern African perspective.
Additive effect of prostaglandin E(2) and adenosine in mouse experimental autoimmune encephalomyelitis.
Relapse of multiple sclerosis in a patient retaining CCR7-expressing T cells in CSF under fingolimod therapy.
Increased thyroid autoimmunity among women with multiple sclerosis in the postpartum setting.
Facial hypersensitivity and trigeminal pathology in mice with experimental autoimmune encephalomyelitis (EAE).
Monitoring game-based motor rehabilitation of patients at home for better plans of care and quality of life.
Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis.
Insights into multiple sclerosis provided by non-coding RNAs: meeting summary from the symposium 'Non-coding RNAs in autoimmune disorders of the central nervous system' on 5 April 2013 in Warsaw, Poland.
MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment.
Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Can we predict the evolution of an unpredictable disease like multiple sclerosis?
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review.
Microwave & magnetic (M(2) ) proteomics of the EAE animal model of multiple sclerosis.
Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies.
Evaluation of Cytokines in Multiple Sclerosis Patients Treated with Mesenchymal Stem Cells.

Pages